STOCK TITAN
  1. Home
  2. News
  3. LFMD

LifeMD Inc - LFMD STOCK NEWS

Welcome to our dedicated news page for LifeMD (Ticker: LFMD), a resource for investors and traders seeking the latest updates and insights on LifeMD.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect LifeMD's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of LifeMD's position in the market.

News
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
Rhea-AI Summary
LifeMD, Inc. (LFMD) declares a cash dividend for its Series A Preferred Stock, offering $0.5546875 per share to holders, payable on April 15, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.34%
Tags
dividends
-
News
LifeMD to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Rhea-AI Summary
LifeMD, Inc. (LFMD) to participate in the 23rd Annual Needham Virtual Healthcare Conference, presenting corporate overview and meeting investors.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.85%
Tags
conferences
-
News
LifeMD Reports Fourth Quarter 2023 Results
Rhea-AI Summary
LifeMD, Inc. (LFMD) reports impressive financial results for Q4 2023 with a 60% revenue increase to $44.9 million and adjusted EPS of $0.15 per share. Telehealth revenues surged 90%, and Weight Management subscribers exceeded 22,000. The company experienced record growth in telehealth and profitability, leading to an adjusted EBITDA of $5.5 million. LifeMD raised its 2024 revenue guidance to at least $200 million, indicating a 31% growth. The company is well-positioned for expansion and aims to maintain its market disruption in telemedicine.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.41%
Tags
earnings
News
LifeMD to Report Fourth Quarter 2023 Financial Results on March 11
Rhea-AI Summary
LifeMD, Inc. (LFMD) will announce financial results for Q4 and full year 2023 on March 11, 2024. The conference call will be held at 4:30 p.m. Eastern time. Investors can dial in to listen to the call or access the webcast.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.71%
Tags
conferences earnings
-
News
LifeMD to Participate in Upcoming Investor Conferences and Webinar
Rhea-AI Summary
LifeMD, Inc. (LFMD) announced participation in multiple investor conferences and a webinar to discuss GLP-1s. CEO Justin Schreiber will be presenting at various events to engage with investors and analysts.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.95%
Tags
conferences
-
News
LifeMD to Participate in the 11th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Rhea-AI Summary
LifeMD, Inc. (LFMD) will participate in the 11th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 13-14, 2024, at the Cliff Lodge in Snowbird, Utah. The company will hold one-on-one meetings during the conference.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.54%
Tags
conferences
News
LifeMD to Participate in the Maxim Group 2024 Healthcare IT Virtual Conference
Rhea-AI Summary
LifeMD, Inc. (LFMD) will participate in the Maxim Group 2024 Healthcare IT Virtual Conference on January 24-25, 2024. The company's management will engage in a virtual fireside chat and one-on-one meetings, offering investors an opportunity to engage with the company.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.01%
Tags
conferences
-
News
LifeMD Provides 2024 Financial Guidance
Rhea-AI Summary
LifeMD, Inc. (LFMD) expects revenue between $195 and $205 million, a 31% to 38% increase over 2023 guidance. Adjusted EBITDA is expected to be between $18 and $22 million, a 71% to 110% increase over the midpoint of 2023 guidance. The company also anticipates positive full-year free cash flow with estimated year-end 2023 cash exceeding $30 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.97%
Tags
none
-
News
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
Rhea-AI Summary
LifeMD, Inc. (Nasdaq: LFMD) authorizes a cash dividend of $0.5546875 per share for its 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP), payable on January 15, 2024, to holders of record on January 5, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.47%
Tags
dividends
News
LifeMD and Medifast Partner to Offer Transformative Weight Management Solution
Rhea-AI Summary
LifeMD, Inc.TM (Nasdaq: LFMD) announced a strategic alliance with Medifast (NYSE: MED) to integrate LifeMD’s telehealth platform and GLP-1 offering for medically qualified patients with OPTAVIA Coach-guided, healthy lifestyle solution. Medifast has invested $20 million, including a $10 million payment in support of the collaboration and a $10 million purchase of LifeMD common stock.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.42%
Tags
partnership
Stock LFMD logo
LifeMD Inc

Nasdaq:LFMD

LFMD Rankings

#3142 Ranked by Market Cap
#43 Ranked by Stock Gains
N/A Ranked by Dividends

LFMD Stock Data

377.59M
30.96M
19.81%
30.8%
6.78%
Medicinal and Botanical Manufacturing
Manufacturing
Link
United States
New York

About LFMD

lifemd is a comprehensive one-stop telemedicine/telehealth solution with a platform that provides a fully integrated telehealth solution to connect physicians, medical providers, pharmacists, and patients worldwide. the platform is hipaa-compliant and all interactions and communication between physicians, healthcare providers and patients are aes-encrypted. the platform allows physicians, healthcare providers and patients to securely connect and manage common medical conditions. lifemd also custom fabricates mobile diagnostic telehealth equipment such as cases, carts and kiosks. the service is available 24/7/365.